Notice2022-05318
Importer of Controlled Substances Application: Sigma Aldrich Co. LLC
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 14, 2022
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Sigma Aldrich Co. LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 49 (Monday, March 14, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 49 (Monday, March 14, 2022)]
[Notices]
[Pages 14291-14292]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-05318]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-981]
Importer of Controlled Substances Application: Sigma Aldrich Co.
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Sigma Aldrich Co. LLC has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 13, 2022. Such persons may also file a written request for a
hearing on the application on or before April 13, 2022.
ADDRESSES: DEA requires that all comments be submitted electronically
through the Federal eRulemaking Portal, which provides the ability to
type short comments directly into the comment field on the web page or
attach a file for lengthier comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the online instructions at that site for
submitting comments. Upon submission of your comment, you will receive
a Comment Tracking Number. Please be aware that submitted comments are
not instantaneously available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have received a Comment Tracking Number,
your comment has been successfully submitted and there is no need to
resubmit the same comment. All requests for a hearing must be sent to:
(1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia 22152; and (2) Drug
Enforcement Administration, Attn: DEA Federal Register Representative/
DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests
for a hearing should also be sent to: Drug Enforcement Administration,
Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on January 21, 2022, Sigma Aldrich Co. LLC, 3500 Dekalb
Street, Saint Louis, Missouri 63118-4103, applied to be registered as
an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone............................. 1235 I
Methcathinone......................... 1237 I
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
Gamma Hydroxybutyric Acid............. 2010 I
Tetrahydrocannabinols................. 7370 I
4-Bromo-2,5-dimethoxyamphetamine...... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine... 7392 I
2,5-Dimethoxyamphetamine.............. 7396 I
3,4-Methylenedioxyamphetamine......... 7400 I
3,4-Methylenedioxy-N-ethylamphetamine. 7404 I
3,4-Methylenedioxymethamphetamine..... 7405 I
4-Methoxyamphetamine.................. 7411 I
Dimethyltryptamine.................... 7435 I
N-Benzylpiperazine.................... 7493 I
Heroin................................ 9200 I
Normorphine........................... 9313 I
Amobarbital........................... 2125 II
Secobarbital.......................... 2315 II
Nabilone.............................. 7379 II
Phencyclidine......................... 7471 II
Ecgonine.............................. 9180 II
Ethylmorphine......................... 9190 II
Levorphanol........................... 9220 II
Meperidine............................ 9230 II
Thebaine.............................. 9333 II
Opium, powdered....................... 9639 II
Levo-alphacetylmethadol............... 9648 II
------------------------------------------------------------------------
[[Page 14292]]
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis. In reference
to drug code 7370 (Tetrahydrocannabinols) the company plans to import
synthetic Tetrahydrocannabinols. No other activity for this drug code
is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-05318 Filed 3-11-22; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on March 14, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.